Completed PHASE2 INTERVENTIONAL 3-arm NCT01585025

Obeticholic Acid in Bile Acid Diarrhoea (OBADIAH1)

Obeticholic Acid Treatment in Patients With Bile Acid Diarrhoea: an Open-label, Pilot Study of Mechanisms, Safety and Symptom Response.

Sponsor: Imperial College Healthcare NHS Trust

Conditions Chronic Diarrhoea Primary Bile Acid Malabsorption Secondary Bile Acid Malabsorption

Interventions Obeticholic acid

Updated 9 times since 2017 Last updated: Mar 8, 2023 Started: Apr 30, 2012 Primary completion: Jan 31, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01585025, this PHASE2 trial focuses on Chronic Diarrhoea and Primary Bile Acid Malabsorption and remains completed. Sponsored by Imperial College Healthcare NHS Trust, it has been updated 9 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2021 — Apr 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Apr 2020 — Jan 2021 [monthly]

Completed PHASE2
Oct 2019 — Apr 2020 [monthly]

Completed PHASE2
Jun 2018 — Oct 2019 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Imperial College Healthcare NHS Trust

Data source: Imperial College Healthcare NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom